Wim Van de Ven

2.2k total citations
23 papers, 1.7k citations indexed

About

Wim Van de Ven is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Wim Van de Ven has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in Wim Van de Ven's work include Sarcoma Diagnosis and Treatment (4 papers), Tumors and Oncological Cases (4 papers) and Renal and related cancers (3 papers). Wim Van de Ven is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Tumors and Oncological Cases (4 papers) and Renal and related cancers (3 papers). Wim Van de Ven collaborates with scholars based in Belgium, United States and Sweden. Wim Van de Ven's co-authors include Isabelle Cleynen, Jeroen Declercq, Frederik Van Dyck, Herman Van den Berghe, Paola Dal Cin, Raf Sciot, Koenraad Devriendt, Caroline Braem, Hilde Van Esch and Peter Groenen and has published in prestigious journals such as Nature, Science and Nature Genetics.

In The Last Decade

Wim Van de Ven

23 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wim Van de Ven Belgium 18 931 476 339 291 237 23 1.7k
Marja Ekblom Sweden 26 961 1.0× 237 0.5× 201 0.6× 209 0.7× 349 1.5× 55 2.9k
Kensei Katsuoka Japan 29 931 1.0× 193 0.4× 223 0.7× 142 0.5× 377 1.6× 130 3.1k
M Sandberg Finland 26 1.2k 1.2× 151 0.3× 389 1.1× 230 0.8× 285 1.2× 39 2.4k
Youngsuk Yi South Korea 13 1.1k 1.2× 185 0.4× 184 0.5× 139 0.5× 247 1.0× 18 1.6k
Te‐Cheng Pan United States 28 1.2k 1.3× 120 0.3× 628 1.9× 428 1.5× 140 0.6× 44 2.4k
J. Rosenbloom United States 25 828 0.9× 391 0.8× 824 2.4× 328 1.1× 76 0.3× 37 2.1k
Linda Howard Ireland 30 1.1k 1.2× 127 0.3× 217 0.6× 407 1.4× 614 2.6× 60 2.7k
Zenzo Isogai Japan 16 643 0.7× 192 0.4× 485 1.4× 338 1.2× 164 0.7× 46 1.5k
R W Glanville United States 22 786 0.8× 198 0.4× 983 2.9× 601 2.1× 208 0.9× 34 2.5k
Donna M. Peters United States 32 1.1k 1.1× 94 0.2× 261 0.8× 596 2.0× 173 0.7× 70 2.9k

Countries citing papers authored by Wim Van de Ven

Since Specialization
Citations

This map shows the geographic impact of Wim Van de Ven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim Van de Ven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim Van de Ven more than expected).

Fields of papers citing papers by Wim Van de Ven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wim Van de Ven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim Van de Ven. The network helps show where Wim Van de Ven may publish in the future.

Co-authorship network of co-authors of Wim Van de Ven

This figure shows the co-authorship network connecting the top 25 collaborators of Wim Van de Ven. A scholar is included among the top collaborators of Wim Van de Ven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim Van de Ven. Wim Van de Ven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Mingli, Houli Li, Jian Kong, et al.. (2015). Dextran-coated superparamagnetic nanoparticles as potential cancer drug carriers in vivo. Nanoscale. 7(25). 11155–11162. 90 indexed citations
2.
Zhu, Jingjing, Wim Van de Ven, & A.J.M. Vermorken. (2013). Polyphenols with indirect proprotein convertase inhibitory activity. International Journal of Oncology. 43(3). 947–955. 3 indexed citations
3.
Declercq, Jeroen, Boudewijn Van Damme, Anton Roebroek, et al.. (2008). MMTV-cre-mediated fur inactivation concomitant with PLAG1 proto-oncogene activation delays salivary gland tumorigenesis in mice. International Journal of Oncology. 32(5). 1073–83. 25 indexed citations
4.
Dyck, Frederik Van, Ilse Scroyen, Jeroen Declercq, et al.. (2008). aP2-Cre-mediated expression activation of an oncogenic PLAG1 transgene results in cavernous angiomatosis in mice. International Journal of Oncology. 32(1). 33–40. 17 indexed citations
5.
Declercq, Jeroen, Frederik Van Dyck, Boudewijn Van Damme, & Wim Van de Ven. (2008). Upregulation of Igf and Wnt signalling associated genes in pleomorphic adenomas of the salivary glands in PLAG1 transgenic mice. International Journal of Oncology. 32(5). 1041–7. 43 indexed citations
6.
Zhou, Wenlai, Lizhu Lin, Årindam Majumdar, et al.. (2007). Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family–mediated transcriptional activation of TGFβ2. Nature Genetics. 39(10). 1225–1234. 138 indexed citations
7.
Cleynen, Isabelle, C. Huysmans, Takehiko Sasazuki, et al.. (2007). Transcriptional Control of the Human High Mobility Group A1 Gene: Basal and Oncogenic Ras-Regulated Expression. Cancer Research. 67(10). 4620–4629. 48 indexed citations
8.
Dyck, Frederik Van, Jeroen Declercq, Caroline Braem, & Wim Van de Ven. (2007). PLAG1, the prototype of the PLAG gene family: Versatility in tumour development (Review). International Journal of Oncology. 30(4). 765–74. 120 indexed citations
9.
Castermans, Dries, Valérie Wilquet, Jean Steyaert, et al.. (2004). Chromosomal Anomalies in Individuals with Autism. Autism. 8(2). 141–161. 30 indexed citations
10.
Esch, Hilde Van, Peter Groenen, M. Andrew Nesbit, et al.. (2000). GATA3 haplo-insufficiency causes human HDR syndrome. Nature. 406(6794). 419–422. 399 indexed citations
11.
Esch, Hilde Van, Peter Groenen, Maureen Holvoet, et al.. (1999). Partial DiGeorge syndrome in two patients with a 10p rearrangement. Clinical Genetics. 55(4). 269–276. 26 indexed citations
12.
13.
Röijer, E., et al.. (1996). Identification of a yeast artificial chromosome spanning the 8q12 translocation breakpoint in pleomorphic adenomas with t(3;8)(p21;q12). Genes Chromosomes and Cancer. 17(3). 166–171. 15 indexed citations
14.
Rosaí, Juan, Måns Åkerman, Paola Dal Cin, et al.. (1996). Combined Morphologic and Karyotypic Study of 59 Atypical Lipomatous Tumors. The American Journal of Surgical Pathology. 20(10). 1182–1189. 150 indexed citations
15.
Mandahl, Nils, Måns Åkerman, Pierre Åman, et al.. (1996). Duplication of chromosome segment 12q15-24 is associated with atypical lipomatous tumors. A report of the CHAMP collaborative study group. International Journal of Cancer. 67(5). 632–635. 31 indexed citations
16.
Cin, Paola Dal, Patrick Kools, Raf Sciot, et al.. (1993). Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genetics and Cytogenetics. 68(2). 85–90. 146 indexed citations
17.
Cin, Paola Dal, et al.. (1993). Rearrangement of 12q14‐15 in pulmonary chondroid hamartoma. Genes Chromosomes and Cancer. 8(2). 131–133. 38 indexed citations
18.
Kas, Koen, Eric Schoenmakers, Wim Van de Ven, et al.. (1993). Assignment of the Human FAU Gene to a Subregion of Chromosome 11q13. Genomics. 17(2). 387–392. 17 indexed citations
19.
Kazmierczak, Bernd, et al.. (1991). Leiomyoma cells with 12q15 aberrations can be transformed in vitro and show a relatively stable karyotype during precrisis period. Cancer Genetics and Cytogenetics. 54(2). 223–228. 10 indexed citations
20.
Groffen, John, et al.. (1982). Isolation of Human Oncogene Sequences (v- fes Homolog) from a Cosmid Library. Science. 216(4550). 1136–1138. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marja Ekblom Breakdown of academic impact, for papers by Kensei Katsuoka Breakdown of academic impact, for papers by M Sandberg Breakdown of academic impact, for papers by Youngsuk Yi Breakdown of academic impact, for papers by Te‐Cheng Pan Breakdown of academic impact, for papers by J. Rosenbloom Breakdown of academic impact, for papers by Linda Howard Breakdown of academic impact, for papers by Zenzo Isogai Breakdown of academic impact, for papers by R W Glanville Breakdown of academic impact, for papers by Donna M. Peters
Rankless by CCL
2026